HSYA could increase calcium ions via TRPV4 channels, activate eNOS and its phosphorylation via protein kinase A, and promote NO production, thereby relaxing blood vessels, indicating that HSYA is a candidate for the treatment of cardiovascular diseases caused by aging [37]. Here, TRPV4 is linked to cardiovascular disorder.